These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37745305)
1. Identification and verification of a prognostic signature based on a miRNA-mRNA interaction pattern in colon adenocarcinoma. Zhao Q; Li H; Li W; Guo Z; Jia W; Xu S; Chen S; Shen X; Wang C Front Cell Dev Biol; 2023; 11():1161667. PubMed ID: 37745305 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs Associated With Colon Cancer: New Potential Prognostic Markers and Targets for Therapy. Zhu J; Xu Y; Liu S; Qiao L; Sun J; Zhao Q Front Bioeng Biotechnol; 2020; 8():176. PubMed ID: 32211396 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma. Wang JY; Wang CL; Wang XM; Liu FJ Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673 [TBL] [Abstract][Full Text] [Related]
4. Development of a novel necroptosis-associated miRNA risk signature to evaluate the prognosis of colon cancer patients. Huang Y; Zou Y; Xiong Q; Zhang C; Sayagués JM; Shelat VG; Wang X Ann Transl Med; 2021 Dec; 9(24):1800. PubMed ID: 35071494 [TBL] [Abstract][Full Text] [Related]
5. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
6. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
7. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
8. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma. Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920 [TBL] [Abstract][Full Text] [Related]
9. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
10. Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma. Ji Y; Wang L; Chang G; Yan J; Dai L; Ji Z; Liu J; He M; Xu H; Zhang L Biol Direct; 2023 Feb; 18(1):5. PubMed ID: 36829221 [TBL] [Abstract][Full Text] [Related]
11. miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma. Xue W; Wang Y; Xie Y; Yang C; Gong Z; Guan C; Wei C; Zhu C; Niu Z Front Oncol; 2021; 11():634841. PubMed ID: 34262855 [TBL] [Abstract][Full Text] [Related]
12. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y Front Genet; 2022; 13():816173. PubMed ID: 35281843 [No Abstract] [Full Text] [Related]
13. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M; Mu J; Wang J; Zhou Q; Wang J Front Oncol; 2022; 12():961213. PubMed ID: 35965536 [TBL] [Abstract][Full Text] [Related]
15. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma. Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014 [No Abstract] [Full Text] [Related]
16. Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma. Xi J; Zhang H; Li Y; Su H; Chen X; Liang X Medicine (Baltimore); 2022 Sep; 101(39):e30681. PubMed ID: 36181111 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
18. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
19. Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics. Jiang D; Xie X; Lu Z; Liu L; Qu Y; Wu S; Li Y; Li G; Wang H; Xu G Front Genet; 2020; 11():560186. PubMed ID: 33193642 [TBL] [Abstract][Full Text] [Related]
20. Identifying a new microRNA signature as a prognostic biomarker in colon cancer. Lv Y; Duanmu J; Fu X; Li T; Jiang Q PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]